“While these events are very rare, we’re recommending a pause in the use of the J&J COVID-19 vaccine in order to prepare the health care system to recognize and treat patients appropriately and to report severe events they may be seeing,” FDA acting Commissioner Janet Woodcock said at a press conference. J&J announced it had decided “to proactively delay the rollout” of the vaccine in Europe, where it has not yet been used, as well. The European Medicines Agency (EMA) announced on Friday it was investigating reports of four clotting cases in the United States following use of the vaccine.
A pigment from red cabbage could help turn your favorite foods blue
Apr. 9, 2021 , 4:15 PM
It’s not that hard to make a natural blue dye. Just take a red cabbage, cut it into pieces, and boil it. What you get is a purple broth that turns bright blue when you add some baking powder.
Children have been doing this for decades, but researchers have struggled to turn this or similar natural blues into a stable and abundant colorant one that could be used to naturally dye your favorite candies, sodas, or ice creams. Now, a team says it has found a way and the key lies in the humble cabbage itself.
email article
Following up on previous reviews of the evidence, the European Medicines Agency (EMA), WHO, and Britain s Medicine s and Healthcare Products Regulatory Agency (MHRA) have issued statements saying that the overall benefits continue to outweigh the risks of very rare blood clots with low platelets reported after the AstraZeneca COVID-19 vaccine.
The WHO now states that a causal relationship is considered plausible but is not confirmed, while the MHRA has said that the evidence is now stronger for a link between the vaccine and these events. The EMA calls these unusual blood clots with low platelets and says they should be listed as very rare side effects of the vaccine.
The AstraZeneca Vaccine Blood-Clot Issue Won t Go Away theatlantic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theatlantic.com Daily Mail and Mail on Sunday newspapers.